Immune Activation Induces Telomeric DNA Damage and Promotes Short‐Lived Effector T Cell Differentiation in Chronic HCV Infection
Lam Nhat Nguyen,Lam Ngoc Thao Nguyen,Juan Zhao,Madison Schank,Xindi Dang,Dechao Cao,Sushant Khanal,Bal Krishna Chand Thakuri,Jinyu Zhang,Zeyuan Lu,Xiao Y. Wu,Mohamed El Gazzar,Shunbin Ning,Ling Wang,Jonathan P. Moorman,Zhi Q. Yao
DOI: https://doi.org/10.1002/hep.32008
IF: 17.298
2021-08-25
Hepatology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Aims</h3><p>Hepatitis C virus (HCV) leads to a high rate of chronic infection and T cell dysfunction. While it is well-known that chronic antigenic stimulation is a driving force for impaired T cell functions, the precise mechanisms underlying immune activation-induced T cell dysfunctions during HCV infection remain elusive.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Approach and Results</h3><p>Here, we demonstrated that circulating CD4<sup>+</sup> T cells from chronically HCV-infected patients exhibit an immune activation status, as evidenced by the overexpression of cell activation markers HLA-DR, GLUT1, Granzyme B, and the short-lived effector marker CD127<sup>-</sup> KLRG1<sup>+</sup>. In contrast, the expression of stem cell-like transcription factor TCF1 and telomeric repeat-binding factor 2 (TRF2) are significantly reduced in CD4<sup>+</sup> T cells from chronically HCV-infected patients compared to healthy subjects (HS). Mechanistic studies revealed that CD4<sup>+</sup> T cells from HCV subjects exhibit PI3K/Akt/mTOR signaling hyperactivation upon T cell receptor (TCR) stimulation, promoting pro-inflammatory effector cell differentiation, telomeric DNA damage, and cellular apoptosis. Inhibition of Akt signaling during T cell activation preserved the precursor memory cell population and prevented inflammatory effector cell expansion, DNA damage, and apoptotic death. Moreover, knockdown of TRF2 reduced HS-T cell stemness and triggered telomeric DNA damage and cellular apoptosis, whereas overexpression of TRF2 in HCV-CD4 T cells prevented telomeric DNA damage. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>These results suggest that modulation of immune activation via inhibiting Akt signaling and protecting telomeres via enhancing TRF2 expression may open new therapeutic strategies to fine-tune the adaptive immune responses in the setting of persistent immune activation and inflammation during chronic HCV infection.</p></section>
gastroenterology & hepatology